August 11th 2025
NRx Pharmaceuticals secures FDA Fast Track designation for NRX-100, a preservation-free formulation of intravenous ketamine for suicidal ideation in depression.
Exploring the Psychosis-Depression Interface: Clinical Implications
October 31st 2016A review of the distinction between depressive and psychotic symptom domains, current knowledge about the etiology and neurobiology of depression and psychosis, and how this knowledge can inform the treatment of patients with features of both.
Read More
Transplant Psychiatry: Psychiatric Care of Organ Donors and Recipients
The authors focus on the psychiatric management of transplant recipients and the evaluation and care of living organ donors.
Read More
Transplant Psychiatry: An Introduction, Part 1
Psychiatrists are playing an ever-increasing role in the evaluation and care of organ transplant candidates and living organ donors-before and after transplant.
Read More
PatientsLikeMe: Crowdsourced Patient Health Data as a Clinical Tool in Psychiatry
September 19th 2016Patients want to know what to expect with a given treatment, how their experiences compare with those of others, or whether they are alone in coping with their conditions. Who best to answer these questions than others like them?
Read More